Nutritional intervention in a patient with oncological treatment for breast cancer after metabolic surgery

Authors

DOI:

https://doi.org/10.70983/bfprc213

Keywords:

Breast cancer, Obesity, Metabolic surgery, Nutrition

Abstract

Introduction: Obesity affects cancer prognosis in all aspects. It has been observed that patients with breast cancer and excess adipose tissue have larger primary tumors and higher rates of lymphatic invasion compared to patients of healthy weight. The most effective alternative for sustained weight loss is metabolic surgery, which has recently been of great interest in the field of cancer. However, to date, the effect on patients undergoing metabolic surgery and who have been diagnosed with cancer a few months after surgery is unknown; therefore, the appropriate nutritional approach and the consequences on the patient's body are unknown.Methodology: A 45-year-old female patient underwent metabolic surgery of the gastric sleeve type 6 months after being diagnosed with stage II-A breast cancer. She attended nutritional consultations every 15 days, during a period of 9 months in which anthropometric data, a questionnaire on symptoms and body composition analysis were obtained. Results: During the intervention period, the relevant changes were made to the nutritional treatment, with respect to tolerance and symptoms. At the end of the treatment, the patient had a reduction of 19.1 kg compared to her initial weight. She reached a BMI of 26.9 kg/m2, which changed her diagnosis from type II obesity to overweight. The loss of MME was only 1.2 kg of the initial muscle and with the nutritional treatment the symptoms associated with the chemotherapy were considerably reduced. Conclusions: It will be observed that the nutritional intervention promptly decreases the appearance of adverse effects after oncological treatments and promotes the maintenance of skeletal muscle mass, even after metabolic surgery. In addition, the decrease in adipose tissue and the points previously mentioned improve the prognosis in patients with breast cancer.

References

Abe, R., N. Kumagai, M. Kimura, A. Hirosaki and T. Nakamura (1976). "Biological characteristics of breast cancer in obesity." Tohoku J Exp Med 120(4): 351-359.

Aminian, A., R. Wilson, A. Al-Kurd, C. Tu, A. Milinovich, M. Kroh, R. J. Rosenthal, S. A. Brethauer, P. R. Schauer, M. W. Kattan, J. C. Brown, N. A. Berger, J. Abraham and S. E. Nissen (2022). "Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity." JAMA 327(24): 2423-2433.

Ansari, S., H. Haboubi and N. Haboubi (2020). "Adult obesity complications: challenges and clinical impact." Ther Adv Endocrinol Metab 11: 2042018820934955.

Arends, J., F. Strasser, S. Gonella, T. S. Solheim, C. Madeddu, P. Ravasco, L. Buonaccorso, M. A. E. de van der Schueren, C. Baldwin, M. Chasen, C. I. Ripamonti and E. G. C. E. a. clinicalguidelines@esmo.org (2021). "Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines(☆)." ESMO Open 6(3): 100092.

Bischoff, S. C. and A. Schweinlin (2020). "Obesity therapy." Clin Nutr ESPEN 38: 9-18.

Calle, E. E., C. Rodriguez, K. Walker-Thurmond and M. J. Thun (2003). "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults." N Engl J Med 348(17): 1625-1638.

Céspedes Quevedo, M. C., Y. L. León Barrios, A. M. Vinent Céspedes and R. J. M. Agüero Martén (2016). "Anemia en pacientes con cáncer expuestos a quimioterapia." 20(8): 1054-1060.

Chango, A. J. B. and S. E. B. J. C. L. R. C. M. Veloz (2023). "Abordaje nutricional en cáncer de mama. Un articulo de revisión." 7(2): 7870-7882.

Deglise, C., C. Bouchardy, M. Burri, M. Usel, I. Neyroud-Caspar, G. Vlastos, P. O. Chappuis, M. Ceschi, S. Ess, M. Castiglione, E. Rapiti and H. M. Verkooijen (2010). "Impact of obesity on diagnosis and treatment of breast cancer." Breast Cancer Res Treat 120(1): 185-193.

Dong, Z., L. Xu, H. Liu, Y. Lv, Q. Zheng and L. Li (2017). "Comparative efficacy of five long-term weight loss drugs: quantitative information for medication guidelines." Obes Rev 18(12): 1377-1385.

Elmaleh-Sachs, A., J. L. Schwartz, C. T. Bramante, J. M. Nicklas, K. A. Gudzune and M. Jay (2023). "Obesity Management in Adults: A Review." JAMA 330(20): 2000-2015.

Garcia-Luna, P. P., J. Parejo Campos and J. L. Pereira Cunill (2006). "[Causes and impact of hyponutrition and cachexia in the oncologic patient]." Nutr Hosp 21 Suppl 3: 10-16.

Lauby-Secretan, B., C. Scoccianti, D. Loomis, Y. Grosse, F. Bianchini, K. Straif and G. International Agency for Research on Cancer Handbook Working (2016). "Body Fatness and Cancer--Viewpoint of the IARC Working Group." N Engl J Med 375(8): 794-798.

Lee, K., L. Kruper, C. M. Dieli-Conwright and J. E. Mortimer (2019). "The Impact of Obesity on Breast Cancer Diagnosis and Treatment." Curr Oncol Rep 21(5): 41.

Palacio, A., D. Quintiliano, I. Lira, P. Navarro, V. Orellana, A. Reyes and D. J. N. H. Henríquez (2019). "Cambios de la composición corporal en pacientes sometidos a cirugía bariátrica: bypass gástrico y gastrectomía en manga." 36(2): 334-339.

Puzziferri, N., T. B. Roshek, 3rd, H. G. Mayo, R. Gallagher, S. H. Belle and E. H. Livingston (2014). "Long-term follow-up after bariatric surgery: a systematic review." JAMA 312(9): 934-942.

Sauter, E. R. (2023). "Obesity, metabolic and bariatric surgery, and cancer prevention: what do we need to learn and how do we get there?" Surg Obes Relat Dis 19(7): 781-787.

Sepúlveda, J. and R. Quintero (2016). Obesidad y cáncer: fisiopatología y evidencia epidemiológica. Rev Médica Risaralda [revista en Internet]. 2016 [citado 3 Jul 2018]; 22 (2):[aprox. 6p].

World Health, O. (2023). "Breast cancer." from https://www.who.int/news-room/fact-sheets/detail/breast-cancer.

Downloads

Published

2025-01-22 — Updated on 2025-01-25